PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,297,293 | -1.9% | 6,563,077 | 0.0% | 0.86% | +15.1% |
| Q2 2023 | $41,084,862 | +31.2% | 6,563,077 | 0.0% | 0.74% | +21.0% |
| Q1 2023 | $31,305,877 | -45.2% | 6,563,077 | 0.0% | 0.62% | -43.7% |
| Q4 2022 | $57,098,770 | -26.9% | 6,563,077 | 0.0% | 1.09% | -24.7% |
| Q3 2022 | $78,101,000 | -16.5% | 6,563,077 | 0.0% | 1.45% | -14.5% |
| Q2 2022 | $93,524,000 | -34.5% | 6,563,077 | -4.3% | 1.70% | -26.8% |
| Q1 2022 | $142,730,000 | -15.7% | 6,855,423 | -6.5% | 2.31% | +6.3% |
| Q4 2021 | $169,333,000 | -22.5% | 7,330,423 | 0.0% | 2.18% | -9.3% |
| Q3 2021 | $218,447,000 | -12.8% | 7,330,423 | 0.0% | 2.40% | -5.2% |
| Q2 2021 | $250,407,000 | +3.9% | 7,330,423 | 0.0% | 2.53% | +12.4% |
| Q1 2021 | $241,098,000 | -46.5% | 7,330,423 | 0.0% | 2.25% | -42.9% |
| Q4 2020 | $450,894,000 | +73.3% | 7,330,423 | 0.0% | 3.95% | +20.6% |
| Q3 2020 | $260,230,000 | – | 7,330,423 | – | 3.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |